APO-QUINAPRIL/HCTZ 12.5 MG
HYDROCHLOROTHIAZIDE : 12.5 MG QUINAPRIL (QUINAPRIL HYDROCHLORIDE) : 20 MG · DIN 02408775 · APOTEX INC
Health Canada status: MARKETED
What is APO-QUINAPRIL/HCTZ?
APO-QUINAPRIL/HCTZ 12.5 MG contains HYDROCHLOROTHIAZIDE : 12.5 MG QUINAPRIL (QUINAPRIL HYDROCHLORIDE) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02408775, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Jun-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02408775 |
|---|---|
| Brand name | APO-QUINAPRIL/HCTZ |
| Generic / active ingredient | HYDROCHLOROTHIAZIDE : 12.5 MG QUINAPRIL (QUINAPRIL HYDROCHLORIDE) : 20 MG |
| Manufacturer | APOTEX INC |
| Strength | 12.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09BA06 QUINAPRIL AND DIURETICS |
| AHFS class | 40:28.20 ; 24:32.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-Jun-2025 |
| Original market date | 2013-08-13 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C09BA06 QUINAPRIL AND DIURETICS. 8 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-QUINAPRIL/HCTZ | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02408767 |
| APO-QUINAPRIL/HCTZ | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02408783 |
| AURO-QUINAPRIL HCTZ | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02473305 |
| AURO-QUINAPRIL HCTZ | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02473291 |
| AURO-QUINAPRIL HCTZ | 25 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02473321 |
| JAMP QUINAPRIL / HCTZ | 12.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02547430 |
| JAMP QUINAPRIL / HCTZ | 20 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02547449 |
| ACCURETIC | 10 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02237367 |
| ACCURETIC | 20 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02237368 |
| ACCURETIC | 25 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02237369 |
Who else supplies QUINAPRIL AND DIURETICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. QUINAPRIL AND DIURETICS appears in 23 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.